---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-120777"
form_type: "8-K/A"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2023-11-22T23:59:59+00:00"
generated_at: "2026-06-07T22:17:22.174393+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals dismisses KPMG as auditor, appoints Salberg & Company

## Summary
- Dismissed KPMG effective Nov 15, 2023; no disagreements in past two fiscal years.
- KPMG's reports for FY2021 and FY2022 included a going concern qualification.
- Material weakness in segregation of duties identified for 2021 through Q3 2022; remediated as of Dec 31, 2022.
- Engaged Salberg & Company as new independent auditor for FY2023, effective Nov 17, 2023.
- No prior consultations with Salberg on any accounting or auditing matters.

## SEC filing metadata
- accession: 0001104659-23-120777
- form_type: 8-K/A
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2023-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000110465923120777/0001104659-23-120777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000110465923120777/tm2331382d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-120777
- JSON: https://secwatch.observer/filing/0001104659-23-120777.json
- Plain text: https://secwatch.observer/filing/0001104659-23-120777.txt

## Key facts
- Auditor Changes
  NRX Pharmaceuticals, Inc. engaged Salberg & Company, P.A. as its auditor.
  - Action: engagement
  - Auditor: Salberg & Company, P.A.
  source text: On November 17, 2023, the Board engaged Salberg & Company, P.A. (“Salberg”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000110465923120777/0001104659-23-120777-index.htm
- Auditor Changes
  NRX Pharmaceuticals, Inc. dismissed KPMG LLP as its auditor.
  - Action: dismissal
  - Auditor: KPMG LLP
  - Successor: Salberg & Company, P.A.
  source text: On November 15, 2023, the Board of Directors (the “Board”) of the Company approved the dismissal of KPMG as the Company’s independent registered public accounting firm, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000110465923120777/0001104659-23-120777-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.